• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Parkin disease: a clinicopathologic entity?帕金森病:一种临床病理实体?
JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.
2
Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions.伴有α-突触核蛋白阳性包涵体的帕金蛋白阳性常染色体隐性青少年帕金森病。
Neurology. 2004 Aug 24;63(4):678-82. doi: 10.1212/01.wnl.0000134657.25904.0b.
3
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.一个患有帕金森症且存在帕金森基因(parkin)突变的家族中的临床及病理异常情况。
Neurology. 2001 Feb 27;56(4):555-7. doi: 10.1212/wnl.56.4.555.
4
Lewy bodies and parkinsonism in families with parkin mutations.携带帕金基因突变的家族中的路易小体与帕金森症
Ann Neurol. 2001 Sep;50(3):293-300. doi: 10.1002/ana.1132.
5
A multidisciplinary study of patients with early-onset PD with and without parkin mutations.一项针对有和没有帕金基因突变的早发性帕金森病患者的多学科研究。
Neurology. 2009 Jan 13;72(2):110-6. doi: 10.1212/01.wnl.0000327098.86861.d4. Epub 2008 Nov 5.
6
Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study.突尼斯一个家族中与帕金基因相关的常染色体隐性帕金森病。临床、遗传及病理学研究。
Parkinsonism Relat Disord. 2003 Jun;9(5):247-51. doi: 10.1016/s1353-8020(03)00016-6.
7
A homozygous parkin p.G284R mutation in a Chinese family with autosomal recessive juvenile parkinsonism.一个患有常染色体隐性青少年帕金森病的中国家庭中存在纯合的帕金森蛋白p.G284R突变。
Neurosci Lett. 2016 Jun 15;624:100-4. doi: 10.1016/j.neulet.2016.05.011. Epub 2016 May 10.
8
Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification.伴有日间波动的常染色体隐性早发性帕金森病:临床病理特征及分子遗传学鉴定
Brain Dev. 2000 Sep;22 Suppl 1:S87-91. doi: 10.1016/s0387-7604(00)00130-3.
9
Morphological substrates of mental dysfunction in Lewy body disease: an update.路易体病精神功能障碍的形态学基础:最新进展
J Neural Transm Suppl. 2000;59:185-212. doi: 10.1007/978-3-7091-6781-6_21.
10
[18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations.[18F] - 多巴PET研究在青少年起病的帕金森病及帕金基因突变患者中的应用
Neurology. 2000 Sep 26;55(6):877-9. doi: 10.1212/wnl.55.6.877.

引用本文的文献

1
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
2
Phase Determination and Demonstration of Parental Mosaicism of Intragenic Deletions Initially Identified by Chromosomal Microarray Analysis.最初通过染色体微阵列分析鉴定的基因内缺失的相位确定及亲代嵌合现象的证实
Genes (Basel). 2025 May 24;16(6):630. doi: 10.3390/genes16060630.
3
Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons.在缺乏parkin的诱导多能干细胞衍生的人类神经元中形成具有种子形成能力的α-突触核蛋白聚集体。
NPJ Parkinsons Dis. 2025 Jun 21;11(1):180. doi: 10.1038/s41531-025-01038-4.
4
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.路易体阴性的LRRK2突变病例中存在大量非包涵体型α-突触核蛋白病理改变。
Acta Neuropathol. 2025 May 2;149(1):41. doi: 10.1007/s00401-025-02871-w.
5
Significance of nicotine and nicotinic acetylcholine receptors in Parkinson's disease.尼古丁和烟碱型乙酰胆碱受体在帕金森病中的意义。
Front Aging Neurosci. 2025 Mar 21;17:1535310. doi: 10.3389/fnagi.2025.1535310. eCollection 2025.
6
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.需要一种个性化且全面的方法来抑制或补充帕金森病中的α-突触核蛋白(SNCA)。
NPJ Parkinsons Dis. 2025 Mar 4;11(1):42. doi: 10.1038/s41531-025-00887-3.
7
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.帕金森病患者脑脊液α-突触核蛋白聚集的影像学标志物。
NPJ Parkinsons Dis. 2025 Jan 3;11(1):7. doi: 10.1038/s41531-024-00854-4.
8
A comprehensive review of natural compounds and their structure-activity relationship in Parkinson's disease: exploring potential mechanisms.帕金森病中天然化合物及其构效关系的综合综述:探索潜在机制
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2229-2258. doi: 10.1007/s00210-024-03462-4. Epub 2024 Oct 11.
9
Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonism.青少年帕金森病PrknR275W小鼠模型中的多巴胺能神经元功能障碍与缺失
Brain. 2024 Dec 3;147(12):4017-4025. doi: 10.1093/brain/awae276.
10
Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W.PRKN 最常见致病性替换 p.R275W 的结构与功能特征。
Cells. 2024 Sep 13;13(18):1540. doi: 10.3390/cells13181540.

本文引用的文献

1
A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.一个携带新型PARK2突变的秘鲁家庭:临床和病理特征
Parkinsonism Relat Disord. 2015 May;21(5):444-8. doi: 10.1016/j.parkreldis.2015.01.005. Epub 2015 Jan 15.
2
Lewy body pathology in a patient with a homozygous parkin deletion.路易体病理改变见于一名纯合子 parkin 缺失患者。
Mov Disord. 2013 Mar;28(3):388-91. doi: 10.1002/mds.25346. Epub 2013 Feb 11.
3
The neuropathology of genetic Parkinson's disease.遗传帕金森病的神经病理学。
Mov Disord. 2012 Jun;27(7):831-42. doi: 10.1002/mds.24962. Epub 2012 Mar 26.
4
Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.早发性帕金森病伴或不伴 parkin 基因突变患者的表型分析。
J Neurol. 2011 Dec;258(12):2260-7. doi: 10.1007/s00415-011-6110-1. Epub 2011 May 29.
5
Mitophagy and Parkinson's disease: the PINK1-parkin link.线粒体自噬与帕金森病:PINK1-帕金蛋白联系
Biochim Biophys Acta. 2011 Apr;1813(4):623-33. doi: 10.1016/j.bbamcr.2010.08.007. Epub 2010 Aug 21.
6
Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.在 PLA2G6 突变相关的儿童和成人发病的肌张力障碍-帕金森病病例中存在广泛的路易体和 tau 沉积。
Neurobiol Aging. 2012 Apr;33(4):814-23. doi: 10.1016/j.neurobiolaging.2010.05.009. Epub 2010 Jul 21.
7
PINK1-linked parkinsonism is associated with Lewy body pathology.PINK1 相关性帕金森病与路易体病理相关。
Brain. 2010 Apr;133(Pt 4):1128-42. doi: 10.1093/brain/awq051. Epub 2010 Mar 30.
8
Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.Parkin 和 PINK1 帕金森病可能代表不同于路易体帕金森病的黑质线粒体细胞病变。
Parkinsonism Relat Disord. 2009 Dec;15(10):721-7. doi: 10.1016/j.parkreldis.2009.09.010. Epub 2009 Oct 7.
9
Lewy body pathology in normal elderly subjects.正常老年受试者中的路易体病理改变。
J Neuropathol Exp Neurol. 2009 Jul;68(7):816-22. doi: 10.1097/NEN.0b013e3181ac10a7.
10
Cell death pathways in Parkinson's disease: role of mitochondria.帕金森病中的细胞死亡途径:线粒体的作用。
Antioxid Redox Signal. 2009 Sep;11(9):2135-49. doi: 10.1089/ars.2009.2624.

帕金森病:一种临床病理实体?

Parkin disease: a clinicopathologic entity?

机构信息

Reta Lila Weston Institute for Neurological Studies, University College London, London, England.

出版信息

JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.

DOI:10.1001/jamaneurol.2013.172
PMID:23459986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4202385/
Abstract

IMPORTANCE

Mutations in the gene encoding parkin (PARK2) are the most common cause of autosomal recessive juvenile-onset and young-onset parkinsonism. The few available detailed neuropathologic reports suggest that homozygous and compound heterozygous parkin mutations are characterized by severe substantia nigra pars compacta neuronal loss.

OBJECTIVE

To investigate whether parkin-linked parkinsonism is a different clinicopathologic entity to Parkinson disease (PD).

DESIGN, SETTING, AND PARTICIPANTS: We describe the clinical, genetic, and neuropathologic findings of 5 unrelated cases of parkin disease and compare them with 5 pathologically confirmed PD cases and 4 control subjects. The PD control cases and normal control subjects were matched first for age at death then disease duration (PD only) for comparison.

RESULTS

Presenting signs in the parkin disease cases were hand or leg tremor often combined with dystonia. Mean age at onset was 34 years; all cases were compound heterozygous for mutations of parkin. Freezing of gait, postural deformity, and motor fluctuations were common late features. No patients had any evidence of cognitive impairment or dementia. Neuronal counts in the substantia nigra pars compacta revealed that neuronal loss in the parkin cases was as severe as that seen in PD, but relative preservation of the dorsal tier was seen in comparison with PD (P = .04). Mild neuronal loss was identified in the locus coeruleus and dorsal motor nucleus of the vagus, but not in the nucleus basalis of Meynert, raphe nucleus, or other brain regions. Sparse Lewy bodies were identified in 2 cases (brainstem and cortex).

CONCLUSIONS AND RELEVANCE

These findings support the notion that parkin disease is characterized by a more restricted morphologic abnormality than is found in PD, with predominantly ventral nigral degeneration and absent or rare Lewy bodies.

摘要

重要性

编码 parkin(PARK2)的基因突变是常染色体隐性遗传少年型和青年型帕金森病的最常见原因。少数可用的详细神经病理学报告表明,纯合和复合杂合 parkin 突变的特征是严重的黑质致密部神经元丧失。

目的

研究 parkin 相关帕金森病是否与帕金森病(PD)存在不同的临床病理实体。

设计、地点和参与者:我们描述了 5 例 parkin 病的临床、遗传和神经病理学发现,并将其与 5 例经病理证实的 PD 病例和 4 例对照进行了比较。PD 对照组病例和正常对照组首先根据死亡年龄进行匹配,然后根据疾病持续时间(仅 PD)进行匹配,以进行比较。

结果

parkin 病病例的首发症状是手部或腿部震颤,常伴有肌张力障碍。发病年龄的平均值为 34 岁;所有病例均为 parkin 基因突变的复合杂合子。步态冻结、姿势畸形和运动波动是常见的晚期特征。没有患者有任何认知障碍或痴呆的证据。黑质致密部的神经元计数显示,parkin 病例的神经元丧失与 PD 一样严重,但与 PD 相比,背层相对保留(P =.04)。蓝斑和迷走神经背核中发现轻度神经元丧失,但核基底节、中缝核或其他脑区没有。在 2 例(脑干和皮质)中发现稀疏的 Lewy 体。

结论和相关性

这些发现支持这样一种观点,即 parkin 病的特征是形态异常比 PD 更局限,主要是腹侧黑质变性,缺乏或罕见 Lewy 体。